验证数据展示
经过测试的应用
Positive FC (Intra) detected in | HeLa cells |
Positive FC detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
Flow Cytometry (FC) | FC : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-10384 targets Cytokeratin 8 in FC (Intra) applications and shows reactivity with human, mouse, rat samples.
经测试应用 | FC (Intra) Application Description |
经测试反应性 | human, mouse, rat |
免疫原 | Cytokeratin 8 fusion protein Ag0488 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | keratin 8 |
别名 | CARD2, Cell and organelle markers, CK 8, CK8, CYK8, Cytokeratin 8, Cytoskeleton Marker, K2C8, K8, keratin 8, KO, KRT8, Type II keratin Kb8 |
计算分子量 | 54 kDa |
观测分子量 | 52 kDa |
GenBank蛋白编号 | BC000654 |
基因名称 | Cytokeratin 8 |
Gene ID (NCBI) | 3856 |
RRID | AB_3083875 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P05787 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9-K23, and the hair keratins Ha1-Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1-K8, and the hair keratins, Hb1-Hb6. KRT8 is often paired with keratin 18 in vivo.
实验方案
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 488 Cytokeratin 8 antibody CL488-10384 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |